Related references
Note: Only part of the references are listed.Diagnosis and management of chronic constipation in adults
Satish S. C. Rao et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Flavonoids in Inflammatory Bowel Disease: A Review
Teresa Vezza et al.
NUTRIENTS (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Experimental design and analysis and their reporting: new guidance for publication in BJP
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
Alexandra Weiss et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centred Pilot Study to Assess the Symptomatic Treatment of Ulcerative Colitis With Cannabidiol
Peter M. Irving et al.
GASTROENTEROLOGY (2015)
Role of Transient Receptor Potential Channels in Intestinal Inflammation and Visceral Pain: Novel Targets in Inflammatory Bowel Diseases
Marta Zielinska et al.
INFLAMMATORY BOWEL DISEASES (2015)
Inflammatory Bowel Disease and the Elderly: A Review
Sasha Taleban et al.
JOURNAL OF CROHNS & COLITIS (2015)
Epidemiology and risk factors for IBD
Ashwin N. Ananthakrishnan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
The GPR55 antagonist CID16020046 protects against intestinal inflammation
A. Stancic et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2015)
Phytochemicals and Their Potential Usefulness in Inflammatory Bowel Disease
Sahil J. Somani et al.
PHYTOTHERAPY RESEARCH (2015)
Polypharmacology Shakes Hands with Complex Aetiopathology
James S. Brodie et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
Francesca Borrelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Naloxegol, a new drug for the treatment of opioid-induced constipation
Maura Corsetti et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels
Raffaele Capasso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Cannabis for Inflammatory Bowel Disease
Timna Naftali et al.
DIGESTIVE DISEASES (2014)
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK
David J. Potter
DRUG TESTING AND ANALYSIS (2014)
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis
Yahiya Y. Syed et al.
DRUGS (2014)
Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohn's Disease
Martin Storr et al.
INFLAMMATORY BOWEL DISEASES (2014)
Neuroplasticity and dysfunction after gastrointestinal inflammation
Stuart M. Brierley et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
Barbara Romano et al.
PHYTOMEDICINE (2014)
Cannabidiol: Promise and Pitfalls
Timothy E. Welty et al.
EPILEPSY CURRENTS (2014)
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
Francesca Borrelli et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
B. Romano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
Jessica Ravikoff Allegretti et al.
INFLAMMATORY BOWEL DISEASES (2013)
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
Giuseppe Esposito et al.
PHYTOTHERAPY RESEARCH (2013)
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
L. De Petrocellis et al.
ACTA PHYSIOLOGICA (2012)
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
Angelo A. Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice
Rudolf Schicho et al.
PHARMACOLOGY (2012)
Phytocannabinoids as novel therapeutic agents in CNS disorders
Andrew J. Hill et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
X. -H. Lin et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice
Fabiana Piscitelli et al.
NUTRITION & METABOLISM (2011)
The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
J. M. Jamontt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol
Gerald T. DeLong et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
Francesca Borrelli et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice
R. Capasso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The endogenous cannabinoid system protects against colonic inflammation
F Massa et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique:: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome
G Kristjánsson et al.
GUT (2004)
Expression of opioid receptors during peripheral inflammation
O Pol et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Medicinal cannabis: is Delta(9)-tetrahydrocannabinol necessary for all its effects?
JD Wilkinson et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil
AA Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
